2 October 2018 - Trade deal extends 'data protection' period for expensive class of medicines to 10 years.
As the winners and losers of the new trade deal between Canada, the U.S., and Mexico are being tallied up, one aspect of the agreement is prompting concerns over increased drug costs for Canadians.
The United States-Mexico-Canada Agreement (USMCA) will extend the minimum "data protection" period for an expensive class of drugs known as biologics to 10 years, up from eight.